Drug Transporter (DT) Information

General Information of DT
DT ID DTD0146
Gene Name SLC22A23
Protein Name Solute carrier family 22 member 23
Gene ID
63027
UniProt ID
A1A5C7
TCDB ID
2.A.1.19.28
3D Structure

Modelled DT Structure

Method: multi-sequence alignment based machine learning

Detail: Structure Info

Synonyms C6orf85; SLC22A23; Solute carrier 22 member 23
DT Family Major Facilitator Superfamily (MFS)
Organic Cation Transporter (OCT) Family
Function This transporter is expressed in a various tissues but no substrates or functions have been identified for it.
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Quetiapine
 Approved Drug Info Schizophrenia 6A20 [1]
References
1 Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics J. 2012 Apr;12(2):165-72.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.